The Next Generation of DCBs Is Here

ANT is committed to solving vascular disease’s most significant challenges through the creative applications of nanotechnology.

Meet the incredible team behind ANT

Marwan Berrada
M.Sc., MBA

Chief Executive Officer

Successful entrepreneur with extensive experience in cardiovascular and endovascular devices

Vinod Labhasetwar
Ph.D.

Scientific Advisor

Professor and Endowed Chair of Nanomedicine, Department of Biomedical Engineering at Cleveland Clinic Lerner Research

Frank Proch

VP, R&D

Angela Mallery

VP, Regulatory Affairs & Quality Assurance

Joey Groszek

Director, Nanoparticle R&D

Mike Hogan

Sr. Director, Engineering

Paul McFeely

Sr. Manager, Quality Assurance 

Prominent Scientific Advisory Board

Azeem Latib, MD

Director, Interventional Cardiology & Structural Heart Interventions, Montefiore Medical Center

Gary Ansel, MD, FACC

System Medical Chief, Vascular Program, OhioHealth

Peter Schneider, MD

Professor of Surgery, Div. of Vascular & Endovascular Surgery, UCSF

Sahil Parikh, MD

Director of Endovascular Services, NewYork-Presbyterian / Columbia University, Irving Medical Center

Mahmood Razavi, MD

Radiology and Vascular and Interventional Radiology, Children’s Health Orange County

Thomas Zeller, MD

Associate Professor in the Angiology Division, Universitaets-Herzzentrum, Freiburg, Bad Krozingen, Germany

Renu Virmani, MD

President of CVPath Institute

Aloke Finn, MD

Medical Director, CVPath Institute and Associate Professor of Medicine, University of Maryland